日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The development of N-α-(2-carboxyl)benzoyl-N(5)-(2-fluoro-1-iminoethyl)-l-ornithine amide (o-F-amidine) and N-α-(2-carboxyl)benzoyl-N(5)-(2-chloro-1-iminoethyl)-l-ornithine amide (o-Cl-amidine) as second generation protein arginine deiminase (PAD) inhibitors

N-α-(2-羧基)苯甲酰-N(5)-(2-氟-1-亚氨基乙基)-1-鸟氨酸酰胺 (oF-脒) 和 N-α-(2-羧基)苯甲酰-N(5)-(2-氯-1-亚氨基乙基)-1-鸟氨酸酰胺 (o-Cl-脒) 作为第二代蛋白质精氨酸脱亚氨酶 (PAD) 抑制剂的开发

Corey P Causey, Justin E Jones, Jessica L Slack, Daisuke Kamei, Larry E Jones, Venkataraman Subramanian, Bryan Knuckley, Pedram Ebrahimi, Alexander A Chumanevich, Yuan Luo, Hiroshi Hashimoto, Mamoru Sato, Lorne J Hofseth, Paul R Thompson

Protein arginine deiminase 4: a target for an epigenetic cancer therapy

蛋白质精氨酸脱亚氨酶 4:表观遗传癌症治疗的靶点

Jessica L Slack, Corey P Causey, Paul R Thompson

Development and use of clickable activity based protein profiling agents for protein arginine deiminase 4

针对蛋白质精氨酸脱亚氨酶 4 的可点击活性蛋白质分析剂的开发和使用

Jessica L Slack, Corey P Causey, Yuan Luo, Paul R Thompson

Autodeimination of protein arginine deiminase 4 alters protein-protein interactions but not activity

蛋白质精氨酸脱亚胺酶 4 的自脱亚胺化会改变蛋白质 - 蛋白质相互作用,但不改变活性

Jessica L Slack, Larry E Jones Jr, Monica M Bhatia, Paul R Thompson